Effect of Lipophilicity on Microneedle-Mediated Iontophoretic Transdermal Delivery Across Human Skin In Vitro

Journal of Pharmaceutical Sciences

Volumn 102, Issue 10, 2013, Pages 3784-3791

  Pawar, Kasturi R ^a   Smith, Forrest ^a   Kolli, Chandra Sekhar ^b   Babu, R Jayachandra ^a  

^a AUBURN UNIVERSITY   (United States)

^b CALIFORNIA NORTHSTATE UNIVERSITY   (United States)

Author keywords

Diffusion; Iontophoresis; Percutaneous; Skin; Transdermal drug delivery

Indexed keywords

ACEBUTOLOL; ATENOLOL; PROPRANOLOL; SOTALOL;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RETENTION; HUMAN; HUMAN TISSUE; HYDROPHILICITY; IN VITRO STUDY; IONTOPHORESIS; LIPOPHILICITY; MICRONEEDLE; MOLECULE; SKIN;

DIFFUSION; IONTOPHORESIS; PERCUTANEOUS; SKIN; TRANSDERMAL DRUG DELIVERY;

ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-ANTAGONISTS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IONTOPHORESIS; NEEDLES; PROPRANOLOL; SKIN;

EID: 84883815286     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23694     Document Type: Article

References (50)

1. Prausnitz MR, Langer R. 2008. Transdermal drug delivery. Nat Biotechnol 26:1261-1268.
2. Brown MB, Traynor MJ, Martin GP, Akomeah FK. 2008. Transdermal drug delivery systems: Skin perturbation devices. Methods Mol Biol 437:119-139.
3. Guy RH. 2010. Transdermal drug delivery. Handb Exp Pharmacol 197:399-410.
4. Herwadkar A, Banga AK. 2012. An update on the application of physical technologies to enhance intradermal and transdermal drug delivery. Ther Deliv 3:339-355.
5. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. 2010. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 1:109-131.
6. Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S. 2005. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci USA 102:4688-4693.
7. Kasha PC, Banga AK. 2008. A review of patent literature for iontophoretic delivery and devices. Recent Pat Drug Deliv Formul 2:41-50.
8. van der Maaden K, Jiskoot W, Bouwstra J. 2012. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 161:645-655.
9. Kalia YN, Naik A, Garrison J, Guy RH. 2004. Iontophoretic drug delivery. Adv Drug Deliv Rev 56:619-658.
10. Essa EA, Bonner MC, Barry BW. 2002. Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery. J Pharm Pharmacol 54:1481-1490.
11. Wang Y, Fan Q, Song Y, Michniak B. 2003. Effects of fatty acids and iontophoresis on the delivery of midodrine hydrochloride and the structure of human skin. Pharm Res 20:1612-1618.
12. Kalaria DR, Patel P, Patravale V, Kalia YN. 2012. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro. Int J Pharm 438:202-208.
13. Singh ND, Banga AK. 2013. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles. J Drug Target 21:354-366.
14. Kim YC, Park JH, Prausnitz MR. 2012. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64:1547-1568.
15. Lee JW, Park JH, Prausnitz MR. 2008. Dissolving microneedles for transdermal drug delivery. Biomaterials 29:2113-2124.
16. Goebel AS, Neubert RH, Wohlrab J. 2011. Dermal targeting of tacrolimus using colloidal carrier systems. Int J Pharm 404:159-168.
17. McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG, Prausnitz MR. 2003. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. Proc Natl Acad Sci USA 100:13755-13760.
18. Migalska K, Morrow DI, Garland MJ, Thakur R, Woolfson AD, Donnelly RF. 2011. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res 28:1919-1930.
19. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EM, Yoong C, Robertson TA, Soyer HP, Roberts MS. 2011. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63:470-491.
20. Coulman SA, Anstey A, Gateley C, Morrissey A, McLoughlin P, Allender C, Birchall JC. 2009. Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm 366:190-200.
21. Sivamani RK, Liepmann D, Maibach HI. 2007. Microneedles and transdermal applications. Expert Opin Drug Deliv 4:19-25.
22. Fukushima K, Ise A, Morita H, Hasegawa R, Ito Y, Sugioka N, Takada K. 2011. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm Res 28:7-21.
23. Burton SA, Ng CY, Simmers R, Moeckly C, Brandwein D, Gilbert T, Johnson N, Brown K, Alston T, Prochnow G, Siebenaler K, Hansen K. 2011. Rapid intradermal delivery of liquid formulations using a hollow microstructured array. Pharm Res 28:31-40.
24. Jayachandra Babu R, Ravis WR, Duran SH, Schumacher J, Cox E, Stahl R, Jones K, Jean Lin YJ, Phillip Lee YH, Parsons DL, Portman EM, Brown SC. 2009. Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin. J Vet Pharmacol Ther 32:388-392.
25. Nolan LM, Corish J, Corrigan OI, Fitzpatrick D. 2007. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. Int J Pharm 341:114-124.
26. Karande P, Mitragotri S. 2009. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta 1788:2362-2373.
27. Kolli CS, Xiao J, Parsons DL, Babu RJ. 2012. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate. Drug Dev Ind Pharm 38:571-576.
28. Kumar V, Banga AK. 2012. Modulated iontophoretic delivery of small and large molecules through microchannels. Int J Pharm 434:106-114.
29. Garland MJ, Caffarel-Salvador E, Migalska K, Woolfson AD, Donnelly RF. 2012. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Release 159:52-59.
30. Katikaneni S, Badkar A, Nema S, Banga AK. 2009. Molecular charge mediated transport of a 13 kD protein across microporated skin. Int J Pharm 378:93-100.
31. Chen H, Zhu H, Zheng J, Mou D, Wan J, Zhang J, Shi T, Zhao Y, Xu H, Yang X. 2009. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release 139:63-72.
32. Pikal MJ. 2001. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 46:281-305.
33. Hirvonen J, Guy RH. 1998. Transdermal iontophoresis: Modulation of electroosmosis by polypeptide. J Control Release 50:283-289.
34. Sieg A, Guy RH, Delgado-Charro MB 2004. Electroosmosis in transdermal iontophoresis: Implications for noninvasive and calibration-free glucose monitoring. Biophys J 87:3344-3350.
35. Morrow DIJ, McCarron PA, Woolfson AD, Donnelly RF. 2007. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J 1:36-59.
36. Modamio P, Lastra CF, Montejo O, Marifio EL. 1996. Development and validation of liquid chromatography methods for the quantitation of propranolol, metoprolol, atenolol and bisoprolol: Application in solution stability studies. Int J Pharm 130:137-140.
37. Abla MJ, Banga AK. 2013. Quantification of skin penetration of antioxidants of varying lipophilicity. Int J Cosmet Sci 35:19-26.
38. Cross SE, Magnusson BM, Winckle G, Anissimov Y, Roberts MS. 2003. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 120:759-764.
39. Mills PC, Magnusson BM, Cross SE. 2003. Effect of solute lipophilicity on penetration through canine skin. Aust Vet J 81:752-755.
40. Yagi S, Nakayama K, Kurosaki Y, Higaki K, Kimura T. 1998. Factors determining drug residence in skin during transdermal absorption: Studies on beta-blocking agents. Biol Pharm Bull 21:1195-1201.
41. Banga AK. 2006. Therapeutic peptides and proteins: Formulation, processing, and delivery systems. In Transdermal and topical delivery of therapeutic peptides; Banga AK, Ed., 2nd ed. Boca Raton, Florida: CRC Press, pp 259-290.
42. Banks SL, Pinninti RR, Gill HS, Paudel KS, Crooks PA, Brogden NK, Prausnitz MR, Stinchcomb AL. 2010. Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs. J Pharm Sci 99:3072-3080.
43. Wagner H, Kostka KH, Lehr CM, Schaefer UF. 2002. Correlation between stratum corneum/water-partition coefficient and amounts of flufenamic acid penetrated into the stratum corneum. J Pharm Sci 91:1915-1921.
44. Kalluri H, Kolli CS, Banga AK. 2011. Characterization of microchannels created by metal microneedles: Formation and closure. AAPS J 13:473-481.
45. Trommer H, Neubert RH. 2006. Overcoming the stratum corneum: The modulation of skin penetration. A review. Skin Pharmacol Physiol 19:106-121.
46. Sachdeva V, Banga AK. 2011. Microneedles and their applications. Recent Pat Drug Deliv Formul 5:95-132.
47. Marro D, Kalia YN, Delgado-Charro MB, Guy RH. 2001. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res 18:1701-1708.
48. Gupta J, Gill HS, Andrews SN, Prausnitz MR. 2011. Kinetics of skin resealing after insertion of microneedles in human subjects. J Control Release 154:148-155.
49. Yamamoto T, Yamamoto Y. 1976. Electrical properties of the epidermal stratum corneum. Med Biol Eng 14:151-158.
50. Prausnitz MR. 1996. The effects of electric current applied to skin: A review for transdermal drug delivery. Adv Drug Deliv Rev 18:395-425.